In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.
Closing remarks. Dr. Joseph L. Mpagi ,Chairperson organizing committee, Head department of Microbiliogy and Immuniology, Busitema University Faculty of HEALTH sciences. 1. Thanked the participants of the conference. 2. Thanked the sponsors of the conference. 3. Encouraged dissemination of recommendations and resolutions made in this conference. 4. Promised to continually ... read more
Sent from my Samsung Galaxy smartphone. read more
Dear Colleagues I think that the positivity rate depends upon epidemiology of TB in the catchment area of the lab, the strategy for identifying presumptive TB patients (e.g. intensified case finding in high HIV prevalence settings may tend to increase the number of presumptive patients for whom bacteriological confirmatory test ... read more
Latent infection and active disease are fairly accepted concepts among TB clinicians. There is, however, an increasing understanding that the difference between these two states is less of a flipped switch between latent and active but rather a complex interaction between human and microbe that starts at the moment of ... read more
ACCESS Health International; HEALTHWork Locations
ONG El Buen PastorWork Locations